02:16 목차 05:29 MedDRA 데이터 검색 및 제시: 고려사항 (DRP:PTC) 10:20 MedDRA 버전 관리 13:07 MedDRA 버전 분석 도구 15:00 표준 검색어 목록(SMQ, Standardised MedDRA Queries) 16:02 쿼리(Query)란? 18:13 퀴즈1 20:59 MedDRA 용어 간 연결 정보 22:46 표준 검색어 목록(SMQ) 24:24 SMQs - 예시 25:46 SMQ 데이터 특성 26:16 포함된 MedDRA 용어 26:44 상세 검색 및 확장 검색 29:05 상세 VS 확장 용어 예시 31:11 알고리즘 SMQ 31:50 알고리즘 SMQ 예시 36:38 계층적 SMQs 37:50 계층적 SMQ 예시 38:54 SMQ 상태/ 용어 상태 40:21 SMQ 버전 관리 41:36 퀴즈2 43:13 퀴즈3 44:36 퀴즈4 47:33 SMQ 이점 및 제한점 50:40 SMQ 보기 MedDRA 브라우저 데모 1:01:57 SMQ ‘실행’ 방법 1:02:29 MSSO 제공 MedDRA 브라우저 1:03:12 MedDRA 브라우저에서 SMQ 분석 기능 1:05:40 예제 질문 1:14:48 SMQ 분석 1:15:40 SMQ 적용 분야 1:17:35 EMA: 실마리정보 탐지 1:18:55 FDA: 의약품 허가사항정보 검토 1:19:43 두 가지 SMQ 데이터 분석 시나리오 1:20:11 시나리오 #1 1:21:50 시나리오 #2 1:23:34 퀴즈5 1:26:10 퀴즈6 1:27:34 맞춤형 검색 1:28:10 맞춤형 검색 - 수정된 SMQs 1:29:09 유효성/효과 부족(SMQ) 1:29:56 맞춤형 검색 - Ad Hoc 쿼리 1:30:58 마무리 1:31:51 질의 응답
@user-tu7cu3pg9y19 күн бұрын
03:13 목차 08:15 MedDRA 데이터 검색 및 제시: 고려사항 문서 08:20 MedDRA 데이터 검색 및 제시: 고려사항 (DRP:PTC) 14:20 DRP:PTC 일반 원칙(소스 데이터의 품질) 15:33 데이터 변환 관련 17:53 WHOART-MedDRA 매핑 브릿지 파일 19;21 DRP:PTC 일반 원칙(데이터 검색 및 제시 관행의 문서화) 27:11 MedDRA 구조 28:14 DRP:PTC 일반 원칙(MedDRA 특성이 미치는 영향- 그룹 용어) 32:53 어떤 수준(Level)에서 검토? - SOC 임상 검사 37:00 DRP:PTC 일반 원칙(MedDRA 버전 관리) 40:25 MedDRA 버전 관리: PT의 수준 하향 변경에 의한 영향 42:28 MedDRA 버전 관리: 일차 SOC 변경에 의한 영향 44:04 MedDRA 버전 분석 도구(1) 52:20 데이터 검색, 제시 및 분석 시 MedDRA 사용 52:44 다축성(Multi-Axiality) 55:50 일차 SOC 별 개요 59:03 일차 SOC 도식화 예시 59:50 일차 SOC 별 출력 결과 예시 1:00:25 퀴즈1 1:02:36 집중 검색(Focused Searchers) 1:07:33 MSSO 제공 MedDRA 브라우저 1:07:39 MDB 및 WBB 특별한 기능 1:07:52 이차 SOC 분석 예시 1:13:40 이차 SOC 분석 및 그룹 용어 분석 1:14:09 이차 SOC 정보 1:16:00 MedDRA를 활용하여 쿼리 만들기 1:16:22 쿼리란? 1:18:05 쿼리와 케이스 검색 1:22:10 쿼리 만들기 전략 팁 1:26:41 예시-심부정맥 1:29:57 심부정맥-사례식별 1:31:29 케이스 검색 데모 1:14:54 쿼리 만들기 - 기억할 점 1:43:08 퀴즈2 1:44:13 퀴즈3 1:46:18 마무리 1:47:25 질의 응답
@user-tu7cu3pg9y19 күн бұрын
02:47 목차 06:20 규제 배경 정보 07:52 투약오류 09:20 EMAGoodPracticeGuide 10:00 FDAGuidances 10:40 국내 규정 12:26 MedDRA 투약 오류 용어 14:18 ICH 지침 문서 14:33 MedDRA 용어 선택: 고려사항 (MTS:PTC) 15:33 MedDRA 고려 사항 동반 문서 18:00 정의 18:22 투약 오류 정의 20:04 제품 사용 개념 21:43 전후 사정을 고려할 것 25:20 제품 사용 개념의 상위 분류 27:26 불완정한 정보 29:09 ‘중립적‘ 대표 용어(PT) 30:34 제품 사용 개념의 포괄적 부류 32:00 ‘중립적‘ 대표 용어(PT) 33:37 MedDRA 브라우저 탐색 39:55 MedDRA 계층 구조 40:10 HGLT 투약 오류 및 기타 제품 사용 오류 및 문제 용어 42:50 퀴즈1 46:00 퀴즈2 47:40 투약 오류 코딩 일반 원칙 47:49 MedDRA 코딩 - 일반 원칙 49:07 투약 오류 코딩을 위한 팁 51:23 ME 코딩을 위한 일반 원칙 52:57 1- PT 투여 오류 사용 55:00 2- 일련의 사례 분할 코딩 57:42 3- PT 허가 외 사용의 의미에 대해 명확히 하기 1:01:44 4- 잠재적 투약 오류 1:04:47 4- 사전 차단된 투약 오류 1:07:40 5- 의약품 사용 시스템의 단계 1:11:28 6- 근본 원인을 코딩 1:14:48 7- 투약 오류를 추론하지 말 것 1:16:43 투약 오류 보고의 분류 1:18:17 투약 오류 및 기타 제품 사용 개념 1:20:07 코딩 연습 #1 1:28:02 코딩 연습 #2 1:36:32 코딩 연습 #3 1:42:52 코딩 연습 #4 1:48:44 코딩 연습 #5 1:54:08 마무리 1:54:50 질의 응답
@user-em5et6ec2fАй бұрын
감사합니다!
@user-ze1ov1ss5f2 ай бұрын
Please accept our thanks for a great presentation , your lecture made me feel as if you were speaking directly to me.
@anaaligieri99163 ай бұрын
Excelente iniciativa. Curso muito bom. Aulas do MedDRA em português serão muito importantes para disseminar essa importante ferramenta na comunidade brasileira e portuguesa. Espero pelos próximos!!
@lauraprodomo29283 ай бұрын
Fernando, parabéns pelo curso!!!! Muito bom!!!!!!!! Muito importante esse treinamento em Português, foi muito esclarecedor! Nós do Brasil esperamos que você continue com esses treinamentos em Português!!
@dr.hemalathaarumugam18563 ай бұрын
Hi Kindly tell us about reconstitution issue
@nickolaus203 ай бұрын
Thank you for these. I'm trying to break into the DS/PV field and taking the MEDDRA exam will hopefully increase my chances.
@weikangguo87644 ай бұрын
Thanks for your vedio. I have a question on how to get the ID for login? Thanks
@MedDRAMSSO4 ай бұрын
Hello! Each subscribing organization has a unique MedDRA ID. If you belong to a subscribing organization, you can use your company email address to retrieve your credentials from the SSA: ssa.meddra.org/ If you don't belong to a subscribing organization, you can subscribe as an individual for $139 annually. More subscription information, can be found on our website: www.meddra.org/subscription-rates
@johng52954 ай бұрын
Awesome.
@PatriciaMozzicato6 ай бұрын
Hello former MSSO Colleagues! What an outstanding video. It’s so great to see so many new and familiar faces, all with the same mission to support users of this amazing tool - MedDRA - that I have known and loved for… well, for a really LONG time! Carry on the great work you do!
@Mack19909 ай бұрын
I liked the Ronnie Coleman slide.
@yujeongchoi40959 ай бұрын
감사합니다!
@ahmedmohammedseid835411 ай бұрын
what are the steps for good case narration writing to report ADR and AEFI?
@vibhakilivayil676211 ай бұрын
How to join for the class to get certificate?please reply
@MedDRAMSSO11 ай бұрын
Hello! To get a certificate you will need to attend a live training. These trainings are free for MedDRA subscribers. If you do not currently belong to a subscribing organization, you can subscribe as an individual for $154 per year. More details can be found here: www.meddra.org/subscription-rates
@kaanakbuga1922 Жыл бұрын
benim bebeğim en akıllı ve güzel eczacı 🥰
@darrellhalaliky3573 Жыл бұрын
"Promo SM"
@user-zf5ob5od5f Жыл бұрын
how does this programme works
@akshaynaik4782 Жыл бұрын
Hi mam can i get your contact number
@user-mi7pe7wq6v Жыл бұрын
24:16 유익한 설명 감사드립니다!!
@MyCodingDiary Жыл бұрын
I love how you break down complex concepts into easy-to-understand steps. Your videos are a true asset to the programming community.✨👀
@cieu104 Жыл бұрын
좋은 영상 감사합니다^^
@farahkafauit8996 Жыл бұрын
Very helpful thank you.
@hyunjoungcho147 Жыл бұрын
Ppt자료는어디서다운받나요?
@Gabojago___ Жыл бұрын
안녕하세요 최근 MedDRA certificate 자격증에 대해 관심을 가지게 되었는데요, 혹시 공부를 어떻게 하면 좋을지 모르겠는데, 어떻게 공부하면 좋을까요?
@MedDRAMSSO Жыл бұрын
Hello! To become a Certified MedDRA Coder you will need to pass the CMC exam. We recommend Coding webinars as well as becoming familiar with the MedDRA Points to Consider Document: www.meddra.org/how-to-use/support-documentation/english
@carpe996 Жыл бұрын
Slides aren't in sync with what you are talking about
@melnie4465 Жыл бұрын
Wonderful presenter!
@Gabojago___ Жыл бұрын
약물감시 관련 직무 준비를 위해 수강했는데, 너무 유익한 영상인거같아요!! 감사합니다
@manishasharma7629 Жыл бұрын
Hii I want to take online class from u
@MedDRAMSSO Жыл бұрын
Hello! Our live presentations are free to subscribers. You can register with your MedDRA ID on our schedule: www.meddra.org/training/schedule If you don't belong to a subscribing organization, you have the option to subscribe as an individual. You can details for that here: www.meddra.org/subscription-rates
@damian3263 Жыл бұрын
🙃 ᑭяỖｍｏ𝓼𝐦
@disney1494 Жыл бұрын
you showed that multiple sclerosis is in two different soc. how would i know which llt to select?
@MedDRAMSSO Жыл бұрын
PT Multiple sclerosis, like approximately 40% of MedDRA PTs, is multi-axial (i.e., it appears in more than one SOC). PT Multiple sclerosis has a primary SOC assignment of Nervous Ssystem disroders (the prime site of manifestation) and a secondary SOC assignment of Immune system disorders (since it is an autoimmune disorder). When you are coding, you would simply select the LLT Multiple sclerosis as the term of choice. Its SOC placement is only relevant if you display your data at the PT level in which case you have to decide whether you want your data ouput to display only the primary SOC or all of the SOCs in which a PT may be found. I would suggest viewing the "MedDRA Coding Basics" webinar to get a better understanding of SOC allocation rules.
@lynnhood39282 жыл бұрын
pքɾօʍօʂʍ 🙂
@phil99022 жыл бұрын
քʀօʍօֆʍ ☺️
@lakshmi55382 жыл бұрын
Thanks for all your efforts - if I would like to join future webinar, please let me know where can I get details
@MedDRAMSSO2 жыл бұрын
Hello! Our live presentations are free to subscribers. You can register with your MedDRA ID on our schedule: www.meddra.org/training/schedule If you don't belong to a subscribing organization, you have the option to subscribe as an individual. You can details for that here: www.meddra.org/subscription-rates
@punitsalimath2252 жыл бұрын
If the reported verbatim is 'NSAID exacerbated respiratory disease', why do we code it to LLT 'Aspirin-exacerbated respiratory disease'? Aspirin is not the only NSAID we have. Moreover, the reported verbatim doesn't mention Asiprin specifically!
@MedDRAMSSO2 жыл бұрын
Hello, the rationale was given in the session. This was coded using medical judgement as a placeholder in version 25.0 awaiting upversioning to 25.1. We acknowledge that the reported verbatim does not state ‘aspirin’ but the medical concept is broadly the same, with another more general LLT of Analgesic asthma syndrome placed under the PT Aspirin-exacerbated respiratory disease, which we could have selected. When coding it we knew that there had been upversioning changes made in version 25.1 to demote the PT to LLT under a newly added PT NSAID exacerbated respiratory disease, see screenshot of supplemental changes below. We showed this in the session, together with screenshots from TM lab showing the subscriber’s request text and the IMO rationale for the addition of the new terms. We stated in the session that although ‘aspirin’ is more specific, this LLT was a placeholder and the term would be upversioned in September.
@ramayanam1002 жыл бұрын
Thanks for the tutorial
@AshokKumar-ix5ov2 жыл бұрын
What particular changes are done in major and for minor ??
@AshokKumar-ix5ov2 жыл бұрын
Hello sir.. ! What includes major and minor changes ?
@MedDRAMSSO2 жыл бұрын
Can you please resubmit your question with more details? What kind of "major" and "minor" changes are you referring to? This clarification will help us to provide you with the best possible answer. Thank you!
@AshokKumar-ix5ov2 жыл бұрын
@@MedDRAMSSO why march update is called as major update And September update is called minor ?
@AshokKumar-ix5ov2 жыл бұрын
@@MedDRAMSSO What major and minor updates are done in the month of march and September what's tha main difference between both the updates?
@MedDRAMSSO2 жыл бұрын
@@AshokKumar-ix5ov Thank you for clarifying your question. The MedDRA release in March of each year (e.g., 23.0, 24.0, 25.0) is considered a "major" or "complex" release because changes can be implemented at any of the five levels of MedDRA (i.e., SOC, HLGT, HLT PT or LLT). The MedDRA release in September of each year (e.g., 23.1, 24.1, 25.1) is considered a "minor" or "simple" release because it only contains changes at the PT and/or LLT levels of MedDRA. You can see the details of the changes which have occurred for any MedDRA release by 1. using the MedDRA Version Analysis Tool (MVAT) to compare the MedDRA release to the previous MedDRA release to see a spreadsheet of the changes OR 2. look in the Version Report which is included in the MedDRA release files - it has a spreadsheet summary of all of the changes in the new version. I hope that this helps.
@AshokKumar-ix5ov2 жыл бұрын
@@MedDRAMSSO Thankyou so much
@bdest39572 жыл бұрын
ρɾσɱσʂɱ
@muhammaduibrahim85172 жыл бұрын
Being Recommended to Dr Ogoh on KZread was a Blessing to me After 2 years of surfing, I have Finally been cured from genital warts Thanks doctor you are indeed a Great doctor and a Savior to our Generation 🥰
@UdayHadkar2 жыл бұрын
Hey Jane. It would be great if you could give us a presentation on what points are considered while creating conventions.
@riac61743 жыл бұрын
What a wonderful, insightful, and interesting presentation on the topic! Thank you, Dr. Richardson & MedDRA MSSO.
@marisle53063 жыл бұрын
Doctor said the Herpes virus does not have medical cure because the virus is capable of hiding within the human cells, it remains protected from your immune system. Herpes isn't a special virus - your immune system has the tools to fight it back. But because it is able to lay dormant in protected cells, your immune system is unable to remove it from your body, But with strong reactive herbal medication is capable of getting rid of the virus gradually and totally from your body without damaging any of your cells , natural herbs kills the virus totally not just reducing the out break. Get natural herbs cure from dr omohan reach him through WhatsApp +2348164816038 dromohanherbalmedicine.webs.com/
@user-dk3dc3dc3x4 жыл бұрын
Can you explain, how can i log in using code? I need get token?
Пікірлер
02:16 목차 05:29 MedDRA 데이터 검색 및 제시: 고려사항 (DRP:PTC) 10:20 MedDRA 버전 관리 13:07 MedDRA 버전 분석 도구 15:00 표준 검색어 목록(SMQ, Standardised MedDRA Queries) 16:02 쿼리(Query)란? 18:13 퀴즈1 20:59 MedDRA 용어 간 연결 정보 22:46 표준 검색어 목록(SMQ) 24:24 SMQs - 예시 25:46 SMQ 데이터 특성 26:16 포함된 MedDRA 용어 26:44 상세 검색 및 확장 검색 29:05 상세 VS 확장 용어 예시 31:11 알고리즘 SMQ 31:50 알고리즘 SMQ 예시 36:38 계층적 SMQs 37:50 계층적 SMQ 예시 38:54 SMQ 상태/ 용어 상태 40:21 SMQ 버전 관리 41:36 퀴즈2 43:13 퀴즈3 44:36 퀴즈4 47:33 SMQ 이점 및 제한점 50:40 SMQ 보기 MedDRA 브라우저 데모 1:01:57 SMQ ‘실행’ 방법 1:02:29 MSSO 제공 MedDRA 브라우저 1:03:12 MedDRA 브라우저에서 SMQ 분석 기능 1:05:40 예제 질문 1:14:48 SMQ 분석 1:15:40 SMQ 적용 분야 1:17:35 EMA: 실마리정보 탐지 1:18:55 FDA: 의약품 허가사항정보 검토 1:19:43 두 가지 SMQ 데이터 분석 시나리오 1:20:11 시나리오 #1 1:21:50 시나리오 #2 1:23:34 퀴즈5 1:26:10 퀴즈6 1:27:34 맞춤형 검색 1:28:10 맞춤형 검색 - 수정된 SMQs 1:29:09 유효성/효과 부족(SMQ) 1:29:56 맞춤형 검색 - Ad Hoc 쿼리 1:30:58 마무리 1:31:51 질의 응답
03:13 목차 08:15 MedDRA 데이터 검색 및 제시: 고려사항 문서 08:20 MedDRA 데이터 검색 및 제시: 고려사항 (DRP:PTC) 14:20 DRP:PTC 일반 원칙(소스 데이터의 품질) 15:33 데이터 변환 관련 17:53 WHOART-MedDRA 매핑 브릿지 파일 19;21 DRP:PTC 일반 원칙(데이터 검색 및 제시 관행의 문서화) 27:11 MedDRA 구조 28:14 DRP:PTC 일반 원칙(MedDRA 특성이 미치는 영향- 그룹 용어) 32:53 어떤 수준(Level)에서 검토? - SOC 임상 검사 37:00 DRP:PTC 일반 원칙(MedDRA 버전 관리) 40:25 MedDRA 버전 관리: PT의 수준 하향 변경에 의한 영향 42:28 MedDRA 버전 관리: 일차 SOC 변경에 의한 영향 44:04 MedDRA 버전 분석 도구(1) 52:20 데이터 검색, 제시 및 분석 시 MedDRA 사용 52:44 다축성(Multi-Axiality) 55:50 일차 SOC 별 개요 59:03 일차 SOC 도식화 예시 59:50 일차 SOC 별 출력 결과 예시 1:00:25 퀴즈1 1:02:36 집중 검색(Focused Searchers) 1:07:33 MSSO 제공 MedDRA 브라우저 1:07:39 MDB 및 WBB 특별한 기능 1:07:52 이차 SOC 분석 예시 1:13:40 이차 SOC 분석 및 그룹 용어 분석 1:14:09 이차 SOC 정보 1:16:00 MedDRA를 활용하여 쿼리 만들기 1:16:22 쿼리란? 1:18:05 쿼리와 케이스 검색 1:22:10 쿼리 만들기 전략 팁 1:26:41 예시-심부정맥 1:29:57 심부정맥-사례식별 1:31:29 케이스 검색 데모 1:14:54 쿼리 만들기 - 기억할 점 1:43:08 퀴즈2 1:44:13 퀴즈3 1:46:18 마무리 1:47:25 질의 응답
02:47 목차 06:20 규제 배경 정보 07:52 투약오류 09:20 EMAGoodPracticeGuide 10:00 FDAGuidances 10:40 국내 규정 12:26 MedDRA 투약 오류 용어 14:18 ICH 지침 문서 14:33 MedDRA 용어 선택: 고려사항 (MTS:PTC) 15:33 MedDRA 고려 사항 동반 문서 18:00 정의 18:22 투약 오류 정의 20:04 제품 사용 개념 21:43 전후 사정을 고려할 것 25:20 제품 사용 개념의 상위 분류 27:26 불완정한 정보 29:09 ‘중립적‘ 대표 용어(PT) 30:34 제품 사용 개념의 포괄적 부류 32:00 ‘중립적‘ 대표 용어(PT) 33:37 MedDRA 브라우저 탐색 39:55 MedDRA 계층 구조 40:10 HGLT 투약 오류 및 기타 제품 사용 오류 및 문제 용어 42:50 퀴즈1 46:00 퀴즈2 47:40 투약 오류 코딩 일반 원칙 47:49 MedDRA 코딩 - 일반 원칙 49:07 투약 오류 코딩을 위한 팁 51:23 ME 코딩을 위한 일반 원칙 52:57 1- PT 투여 오류 사용 55:00 2- 일련의 사례 분할 코딩 57:42 3- PT 허가 외 사용의 의미에 대해 명확히 하기 1:01:44 4- 잠재적 투약 오류 1:04:47 4- 사전 차단된 투약 오류 1:07:40 5- 의약품 사용 시스템의 단계 1:11:28 6- 근본 원인을 코딩 1:14:48 7- 투약 오류를 추론하지 말 것 1:16:43 투약 오류 보고의 분류 1:18:17 투약 오류 및 기타 제품 사용 개념 1:20:07 코딩 연습 #1 1:28:02 코딩 연습 #2 1:36:32 코딩 연습 #3 1:42:52 코딩 연습 #4 1:48:44 코딩 연습 #5 1:54:08 마무리 1:54:50 질의 응답
감사합니다!
Please accept our thanks for a great presentation , your lecture made me feel as if you were speaking directly to me.
Excelente iniciativa. Curso muito bom. Aulas do MedDRA em português serão muito importantes para disseminar essa importante ferramenta na comunidade brasileira e portuguesa. Espero pelos próximos!!
Fernando, parabéns pelo curso!!!! Muito bom!!!!!!!! Muito importante esse treinamento em Português, foi muito esclarecedor! Nós do Brasil esperamos que você continue com esses treinamentos em Português!!
Hi Kindly tell us about reconstitution issue
Thank you for these. I'm trying to break into the DS/PV field and taking the MEDDRA exam will hopefully increase my chances.
Thanks for your vedio. I have a question on how to get the ID for login? Thanks
Hello! Each subscribing organization has a unique MedDRA ID. If you belong to a subscribing organization, you can use your company email address to retrieve your credentials from the SSA: ssa.meddra.org/ If you don't belong to a subscribing organization, you can subscribe as an individual for $139 annually. More subscription information, can be found on our website: www.meddra.org/subscription-rates
Awesome.
Hello former MSSO Colleagues! What an outstanding video. It’s so great to see so many new and familiar faces, all with the same mission to support users of this amazing tool - MedDRA - that I have known and loved for… well, for a really LONG time! Carry on the great work you do!
I liked the Ronnie Coleman slide.
감사합니다!
what are the steps for good case narration writing to report ADR and AEFI?
How to join for the class to get certificate?please reply
Hello! To get a certificate you will need to attend a live training. These trainings are free for MedDRA subscribers. If you do not currently belong to a subscribing organization, you can subscribe as an individual for $154 per year. More details can be found here: www.meddra.org/subscription-rates
benim bebeğim en akıllı ve güzel eczacı 🥰
"Promo SM"
how does this programme works
Hi mam can i get your contact number
24:16 유익한 설명 감사드립니다!!
I love how you break down complex concepts into easy-to-understand steps. Your videos are a true asset to the programming community.✨👀
좋은 영상 감사합니다^^
Very helpful thank you.
Ppt자료는어디서다운받나요?
안녕하세요 최근 MedDRA certificate 자격증에 대해 관심을 가지게 되었는데요, 혹시 공부를 어떻게 하면 좋을지 모르겠는데, 어떻게 공부하면 좋을까요?
Hello! To become a Certified MedDRA Coder you will need to pass the CMC exam. We recommend Coding webinars as well as becoming familiar with the MedDRA Points to Consider Document: www.meddra.org/how-to-use/support-documentation/english
Slides aren't in sync with what you are talking about
Wonderful presenter!
약물감시 관련 직무 준비를 위해 수강했는데, 너무 유익한 영상인거같아요!! 감사합니다
Hii I want to take online class from u
Hello! Our live presentations are free to subscribers. You can register with your MedDRA ID on our schedule: www.meddra.org/training/schedule If you don't belong to a subscribing organization, you have the option to subscribe as an individual. You can details for that here: www.meddra.org/subscription-rates
🙃 ᑭяỖｍｏ𝓼𝐦
you showed that multiple sclerosis is in two different soc. how would i know which llt to select?
PT Multiple sclerosis, like approximately 40% of MedDRA PTs, is multi-axial (i.e., it appears in more than one SOC). PT Multiple sclerosis has a primary SOC assignment of Nervous Ssystem disroders (the prime site of manifestation) and a secondary SOC assignment of Immune system disorders (since it is an autoimmune disorder). When you are coding, you would simply select the LLT Multiple sclerosis as the term of choice. Its SOC placement is only relevant if you display your data at the PT level in which case you have to decide whether you want your data ouput to display only the primary SOC or all of the SOCs in which a PT may be found. I would suggest viewing the "MedDRA Coding Basics" webinar to get a better understanding of SOC allocation rules.
pքɾօʍօʂʍ 🙂
քʀօʍօֆʍ ☺️
Thanks for all your efforts - if I would like to join future webinar, please let me know where can I get details
Hello! Our live presentations are free to subscribers. You can register with your MedDRA ID on our schedule: www.meddra.org/training/schedule If you don't belong to a subscribing organization, you have the option to subscribe as an individual. You can details for that here: www.meddra.org/subscription-rates
If the reported verbatim is 'NSAID exacerbated respiratory disease', why do we code it to LLT 'Aspirin-exacerbated respiratory disease'? Aspirin is not the only NSAID we have. Moreover, the reported verbatim doesn't mention Asiprin specifically!
Hello, the rationale was given in the session. This was coded using medical judgement as a placeholder in version 25.0 awaiting upversioning to 25.1. We acknowledge that the reported verbatim does not state ‘aspirin’ but the medical concept is broadly the same, with another more general LLT of Analgesic asthma syndrome placed under the PT Aspirin-exacerbated respiratory disease, which we could have selected. When coding it we knew that there had been upversioning changes made in version 25.1 to demote the PT to LLT under a newly added PT NSAID exacerbated respiratory disease, see screenshot of supplemental changes below. We showed this in the session, together with screenshots from TM lab showing the subscriber’s request text and the IMO rationale for the addition of the new terms. We stated in the session that although ‘aspirin’ is more specific, this LLT was a placeholder and the term would be upversioned in September.
Thanks for the tutorial
What particular changes are done in major and for minor ??
Hello sir.. ! What includes major and minor changes ?
Can you please resubmit your question with more details? What kind of "major" and "minor" changes are you referring to? This clarification will help us to provide you with the best possible answer. Thank you!
@@MedDRAMSSO why march update is called as major update And September update is called minor ?
@@MedDRAMSSO What major and minor updates are done in the month of march and September what's tha main difference between both the updates?
@@AshokKumar-ix5ov Thank you for clarifying your question. The MedDRA release in March of each year (e.g., 23.0, 24.0, 25.0) is considered a "major" or "complex" release because changes can be implemented at any of the five levels of MedDRA (i.e., SOC, HLGT, HLT PT or LLT). The MedDRA release in September of each year (e.g., 23.1, 24.1, 25.1) is considered a "minor" or "simple" release because it only contains changes at the PT and/or LLT levels of MedDRA. You can see the details of the changes which have occurred for any MedDRA release by 1. using the MedDRA Version Analysis Tool (MVAT) to compare the MedDRA release to the previous MedDRA release to see a spreadsheet of the changes OR 2. look in the Version Report which is included in the MedDRA release files - it has a spreadsheet summary of all of the changes in the new version. I hope that this helps.
@@MedDRAMSSO Thankyou so much
ρɾσɱσʂɱ
Being Recommended to Dr Ogoh on KZread was a Blessing to me After 2 years of surfing, I have Finally been cured from genital warts Thanks doctor you are indeed a Great doctor and a Savior to our Generation 🥰
Hey Jane. It would be great if you could give us a presentation on what points are considered while creating conventions.
What a wonderful, insightful, and interesting presentation on the topic! Thank you, Dr. Richardson & MedDRA MSSO.
Doctor said the Herpes virus does not have medical cure because the virus is capable of hiding within the human cells, it remains protected from your immune system. Herpes isn't a special virus - your immune system has the tools to fight it back. But because it is able to lay dormant in protected cells, your immune system is unable to remove it from your body, But with strong reactive herbal medication is capable of getting rid of the virus gradually and totally from your body without damaging any of your cells , natural herbs kills the virus totally not just reducing the out break. Get natural herbs cure from dr omohan reach him through WhatsApp +2348164816038 dromohanherbalmedicine.webs.com/
Can you explain, how can i log in using code? I need get token?
Thank you very much Judy and Patrick....👏👏👏